Good Perspective! Maybe there is still hope.
Re-read the 6th September Covid- 19 Trial Update (ADDENDUM SUMMARY OF BIT225-012 DESIGN)
Its states primary end point was nasal swabs – not meet
It states secondary objectives are the bloods “Characterisedisease-specific immune and inflammatory markers, including CD8 counts, CD4/CD8ratio, pro-inflammatory cytokines, including IL-1β, IL-6, and markers ofinflammation, such as sCD163”
They have not yet reported on the secondary objectives – so still in play?
Good Perspective! Maybe there is still hope. Re-read the 6th...
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
